Henry Schein Buys Vaccine Supplier

Share this article:
Healthcare products direct marketer Henry Schein Inc., Melville, NY, announced Dec. 29 that it will acquire General Injectables and Vaccines for $65 million in cash and up to $80 million in additional sales incentives. The acquisition of GIV, Bastian, VA, is Schein's sixth of 1998 and fourth in the United States. The direct-to-physician supplier also has purchased Bedsole Medical Co., Mobile, AL, Columbia Medical, Columbia, MD, and Meer Dental Supply, Canton, MI, with combined annual revenues of $217 million. GIV's annual revenues for 1998 are an estimated $118 million. GIV will become part of Schein's Medical Group but will operate as a stand-alone company. It distributes vaccines to 32,000 medical office customers through a 50-person call center that handles more than 1 million calls per year. The acquisition expands Schein's position in the vaccine market, which CEO Stanley Bergman predicts will see annual growth of 15 percent for the next five years.
Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

Are You Really Ready for Customer Experience?

Are You Really Ready for Customer Experience?

Marketers can talk a good game about customer centricity, but actions speak louder than words.

Essentials in Content Marketing: Think like a best-selling author

Essentials in Content Marketing: Think like a best-selling ...

Imagine if all the electronic content thrown your way daily was actually printed on paper. To stand out from those piles of worthless pixels, you must offer your audiences intriguing ...

The Mobile-Email Marriage

The Mobile-Email Marriage

Marketers who considered leaving email at the altar are finding renewed passion for the channel as an ever-increasing number of customers triage, read, and click-through email on their smartphones.